시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
세계의 옥시코돈 염산염 시장 보고서(2025년)
Oxycodone Hydrochloride Global Market Report 2025
상품코드 : 1769699
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 175 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ￦ 6,471,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ￦ 9,354,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ￦ 12,236,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

옥시코돈 염산염 시장 규모는 향후 수 년간 꾸준히 성장할 것으로 예상됩니다. 이러한 미래 성장의 예상되는 원동력으로는 만성 통증 사례의 지속적인 증가, 수술 후 중재의 상승 추세, 더 광범위한 암 진단, 노인 인구의 지속적인 성장, 정형외과 합병증의 더 큰 발생 등이 있습니다. 예측 기간 중에 예상되는 선진 패키징의 동향에는 남용 억제 기술의 진보, 서방형 제제의 처방, 맞춤형 치료를 위한 약리 유전학의 통합, 변조 방지 포장의 혁신, 방출 제어형 약물전달 시스템의 개량 등이 포함됩니다.

만성 통증의 유병률의 상승은 옥시코돈 염산염 시장의 성장을 가속할 것으로 예측됩니다. 이러한 유병률 증가는 주로 비만율 증가에 기인하며, 과도한 체중이 관절과 근육에 추가적인 압력을 가하여 골관절염과 요통과 같은 질환으로 이어지기 때문입니다. Office for Health Improvement and Disparities는 16세 이상의 개인 17.6%가 2022년에는 관절염과 지속적인 등과 관절 문제 등 장기적인 근골격계의 상태에 있으며, 2021년 17.0%에서 증가하고 있다고 보고했습니다.

옥시코돈 염산염 시장의 주요 기업은 오피오이드 의존의 위험을 줄이면서 통증 관리를 개선하기 위해 병용 요법을 포함한 선진 제품의 개발에 주력하고 있습니다. 위의 약제를 병용하는 것으로, 치료 효과를 높이거나, 복수의 작용기전을 타겟으로 하거나, 내성 리스크를 저하시키거나 하는 것입니다. 예를 들면, 2025년 4월, 미국의 제약회사 Elite Pharmaceuticals Inc.는 페르코셋 제네릭 의약품(옥시코돈 하이드로 클로라이드 및 아세트 아미노펜 정제, USP CII)를 출시했습니다. 이 제품은 3 개의 강도 -mg/325mg, 10mg/325mg, 325mg 정제가 있으며 중등도에서 중등도의 통증을 완화하는 데 사용됩니다. 진통효과가 있는 옥시코돈에 진통효과를 높이는 아세트아미노펜을 배합한 것입니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

SHW
영문 목차

영문목차

Oxycodone hydrochloride is a potent opioid analgesic used to relieve moderate to severe pain. It works by binding to opioid receptors in the brain and spinal cord to reduce the perception of pain. It is frequently prescribed for managing pain following surgery or injury and for long-term conditions that involve chronic pain.

The primary forms of oxycodone hydrochloride include extended-release tablets, immediate-release tablets, oral solutions, and extended-release capsules. Extended-release tablets are formulated to gradually release the drug over an extended period, ensuring consistent therapeutic levels and minimizing the need for frequent dosing. This medication can be administered orally or through parenteral routes and is widely used to treat various types of pain, such as pain resulting from surgery or cancer. It is distributed through several channels, including hospital pharmacies, retail pharmacies, and online pharmacies, and is utilized across various settings such as hospitals, clinics, and home care environments.

The oxycodone hydrochloride market research report is one of a series of new reports from The Business Research Company that provides oxycodone hydrochloride market statistics, including the oxycodone hydrochloride industry's global market size, regional shares, competitors with the oxycodone hydrochloride market share, detailed oxycodone hydrochloride market segments, market trends and opportunities, and any further data you may need to thrive in the oxycodone hydrochloride market. This oxycodone hydrochloride market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The oxycodone hydrochloride market size has grown steadily in recent years. It will grow from $4.15 billion in 2024 to $4.32 billion in 2025 at a compound annual growth rate (CAGR) of 4.0%. The historical growth was influenced by an increasing prevalence of chronic pain conditions, a higher volume of surgical procedures, a surge in cancer diagnoses, an expanding aging population, and the escalating incidence of orthopedic ailments.

The oxycodone hydrochloride market size is expected to see steady growth in the next few years. It will grow to $5.01 billion in 2029 at a compound annual growth rate (CAGR) of 3.7%. Anticipated drivers of this future growth include the persistent rise in chronic pain cases, an uptrend in post-surgical interventions, more widespread cancer diagnoses, continued growth in the elderly demographic, and a greater occurrence of orthopedic complications. Prominent trends expected during the forecast period encompass the advancement of abuse-deterrent technologies, formulation of extended-release options, integration of pharmacogenomics for personalized treatment, tamper-resistant packaging innovations, and improvements in controlled-release drug delivery systems.

The rising prevalence of chronic pain is anticipated to drive the growth of the oxycodone hydrochloride market. Chronic pain is defined as pain that persists for more than three months and continues beyond the typical healing time of an injury or illness. This growing prevalence is mainly due to increasing rates of obesity, as excess body weight places additional pressure on joints and muscles, leading to conditions such as osteoarthritis and lower back pain. Oxycodone hydrochloride supports chronic pain management by delivering effective relief from moderate to severe pain, improving patient comfort and overall quality of life by targeting pain receptors in the nervous system. For example, in March 2023, the Office for Health Improvement and Disparities, a UK government department, reported that 17.6% of individuals aged 16 and over had a long-term musculoskeletal condition such as arthritis or persistent back or joint problems in 2022, up from 17.0% in 2021. This trend underscores how the increasing prevalence of chronic pain is contributing to the market growth of oxycodone hydrochloride.

Key players in the oxycodone hydrochloride market are concentrating on the development of advanced products, including combination therapies, to improve pain management while mitigating the risk of opioid dependency. Combination therapies involve using two or more medications together to boost treatment effectiveness, target multiple mechanisms of action, or lower the risk of resistance. For instance, in April 2025, Elite Pharmaceuticals Inc., a US-based pharmaceutical firm, launched a generic version of Percocet (oxycodone hydrochloride and acetaminophen tablets, USP CII). This product is available in three strengths-mg/325 mg, 10 mg/325 mg, and 325 mg tablets-and is used to relieve moderate to moderately severe pain. The formulation combines oxycodone for strong pain relief with acetaminophen to enhance analgesic efficacy. As a Schedule II controlled substance, it has a high potential for abuse and dependence and thus requires strict medical oversight.

In June 2024, Elite Pharmaceuticals Inc., a US-based pharmaceutical company, entered a partnership with Nostrum Laboratories Inc. to acquire three approved abbreviated new drug applications (ANDAs) for generic versions of Norco, Percocet, and Dolophine. This collaboration seeks to broaden their range of generic opioid analgesics, strengthen their presence in pain management, and provide patients with more affordable alternatives to branded pain relief medications. Nostrum Laboratories Inc. is a US-based company that manufactures prescription medications, including an oral solution that combines oxycodone hydrochloride and acetaminophen.

Major players in the oxycodone hydrochloride market are Viatris Inc., Teva Pharmaceutical Industries Ltd., Daiichi Sankyo Company Ltd., Sun Pharmaceutical Industries Ltd., Endo Pharmaceuticals Inc., Lupin Ltd, Mallinckrodt Pharmaceuticals Inc., Euroapi SA, Ani Pharmaceuticals Inc., Purdue Pharma LLP, Chattem Chemicals Inc., Mayne Pharma Group Limited, Alvogen Inc., Veranova, Temad Co., Camber Pharmaceuticals, Noramco Inc., Saneca Pharma A.S., Rhodes Pharmaceuticals, and Arevipharma GmbH.

North America was the largest region in the oxycodone hydrochloride market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in oxycodone hydrochloride report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the oxycodone hydrochloride market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The oxycodone hydrochloride market consists of sales of oxycodone injectable formulations, oxycodone nasal sprays, oxycodone suppositories, and percocet. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Oxycodone Hydrochloride Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on oxycodone hydrochloride market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for oxycodone hydrochloride ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The oxycodone hydrochloride market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Oxycodone Hydrochloride Market Characteristics

3. Oxycodone Hydrochloride Market Trends And Strategies

4. Oxycodone Hydrochloride Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Oxycodone Hydrochloride Growth Analysis And Strategic Analysis Framework

6. Oxycodone Hydrochloride Market Segmentation

7. Oxycodone Hydrochloride Market Regional And Country Analysis

8. Asia-Pacific Oxycodone Hydrochloride Market

9. China Oxycodone Hydrochloride Market

10. India Oxycodone Hydrochloride Market

11. Japan Oxycodone Hydrochloride Market

12. Australia Oxycodone Hydrochloride Market

13. Indonesia Oxycodone Hydrochloride Market

14. South Korea Oxycodone Hydrochloride Market

15. Western Europe Oxycodone Hydrochloride Market

16. UK Oxycodone Hydrochloride Market

17. Germany Oxycodone Hydrochloride Market

18. France Oxycodone Hydrochloride Market

19. Italy Oxycodone Hydrochloride Market

20. Spain Oxycodone Hydrochloride Market

21. Eastern Europe Oxycodone Hydrochloride Market

22. Russia Oxycodone Hydrochloride Market

23. North America Oxycodone Hydrochloride Market

24. USA Oxycodone Hydrochloride Market

25. Canada Oxycodone Hydrochloride Market

26. South America Oxycodone Hydrochloride Market

27. Brazil Oxycodone Hydrochloride Market

28. Middle East Oxycodone Hydrochloride Market

29. Africa Oxycodone Hydrochloride Market

30. Oxycodone Hydrochloride Market Competitive Landscape And Company Profiles

31. Oxycodone Hydrochloride Market Other Major And Innovative Companies

32. Global Oxycodone Hydrochloride Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Oxycodone Hydrochloride Market

34. Recent Developments In The Oxycodone Hydrochloride Market

35. Oxycodone Hydrochloride Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기